학술논문
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, 1 February 2018, 168(1):127-134)
Subject
Language
English
ISSN
15737217
01676806
01676806